Page last updated: 2024-12-06
piaselenole
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
piaselenole: for determination of traces of selenium; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 67503 |
SCHEMBL ID | 766609 |
MeSH ID | M0126241 |
Synonyms (41)
Synonym |
---|
2lambda4,1,3-benzoselenadiazole |
EN300-17451 |
22706-23-6 |
benzoselenadiazole, 2,1,3- |
benzo-2,1,3-selenadiazole |
AG-690/11353667 |
2,1,3-benzoselenadiazole |
273-15-4 |
inchi=1/c6h4n2se/c1-2-4-6-5(3-1)7-9-8-6/h1-4 |
piaselenole |
nsc-408467 |
piazselenol |
phenylpiazselenole |
3,2,5-selenadiazole |
nsc408467 |
benzo-2,3-selenadiazole |
2,3-benzoselenadiazole |
2-selena-1,3-diaza-2h-isoindene |
piazselenole |
AKOS000279187 |
AKOS001040672 |
STK743029 |
unii-44z4759eku |
nsc 408467 |
ai3-52289 |
einecs 205-986-8 |
44z4759eku , |
3,4-benzo-1,2,5-selenadiazole |
BBL012553 |
benzo[c][1,2,5]selenadiazole |
SCHEMBL766609 |
AYTPIVIDHMVGSX-UHFFFAOYSA-N |
B4313 |
DTXSID60181743 |
mfcd00022886 |
J-016729 |
benzo-1,2,5-selenadiazole |
T70699 |
CS-0356772 |
2|e4|a2-2,1,3-benzoselenadiazole |
Z56941035 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (11)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (18.18) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (27.27) | 29.6817 |
2010's | 6 (54.55) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.55
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.55) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 14 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |